IFNG and neoplasm: As shown in Figure 7A and 7B, tumor masses from mice treated with STM showed a significantly increased production, per mg of masses, of both IFN-γ and IL-1β cytokines at 30 days PTI (P < 0.01; Figure 7), whereas the IL-1β was increased already at 10 days PTI (P < 0.01, Supplementary Figure S6).